Alector Inc. (ALEC)
NASDAQ: ALEC
· Real-Time Price · USD
1.57
0.06 (3.97%)
At close: Jun 17, 2025, 10:38 AM
3.97% (1D)
| Bid | 1.57 |
| Market Cap | 157.49M |
| Revenue (ttm) | 88.34M |
| Net Income (ttm) | -123.44M |
| EPS (ttm) | -1.26 |
| PE Ratio (ttm) | -1.25 |
| Forward PE | -0.96 |
| Analyst | Buy |
| Ask | 1.58 |
| Volume | 107,024 |
| Avg. Volume (20D) | 876,596 |
| Open | 1.49 |
| Previous Close | 1.51 |
| Day's Range | 1.50 - 1.58 |
| 52-Week Range | 0.87 - 6.78 |
| Beta | 0.72 |
About ALEC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALEC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALEC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-13.1%
Alector shares are trading lower after the company...
Unlock content with
Pro Subscription
6 months ago
-35.1%
Alector shares are trading lower after the company announced that the INVOKE-2 Phase 2 clinical trial evaluating the safety and efficacy of AL002 in individuals with early Alzheimer's disease failed to meet its primary endpoint.
